Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 308

1.

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group.

BMC Neurol. 2016 Apr 6;16:44. doi: 10.1186/s12883-016-0567-6. No abstract available.

2.

Measuring the Burden of Hospitalization in Patients with Parkinson´s Disease in Spain.

Gil-Prieto R, Pascual-Garcia R, San-Roman-Montero J, Martinez-Martin P, Castrodeza-Sanz J, Gil-de-Miguel A.

PLoS One. 2016 Mar 15;11(3):e0151563. doi: 10.1371/journal.pone.0151563. eCollection 2016.

3.

Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations.

Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A; Movement Disorders Society Rating Scales Committee.

Mov Disord. 2016 Mar 4. doi: 10.1002/mds.26572. [Epub ahead of print] Review.

PMID:
26945525
4.

Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.

de Pedro-Cuesta J, Martínez-Martín P, Rábano A, Alcalde-Cabero E, José García López F, Almazán-Isla J, Ruiz-Tovar M, Medrano MJ, Avellanal F, Calero O, Calero M.

J Alzheimers Dis. 2016 Feb 25;51(4):1003-22. doi: 10.3233/JAD-150884.

PMID:
26923014
5.

Evaluation of severity of predominantly non-dopaminergic symptoms in Parkinson's disease: The SENS-PD scale.

van der Heeden JF, Marinus J, Martinez-Martin P, van Hilten JJ.

Parkinsonism Relat Disord. 2016 Apr;25:39-44. doi: 10.1016/j.parkreldis.2016.02.016. Epub 2016 Feb 17.

PMID:
26922004
6.

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group.

BMC Neurol. 2016 Feb 25;16:26. doi: 10.1186/s12883-016-0548-9. Erratum in: BMC Neurol. 2016;16:44.

7.

Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population.

Ambrosio L, Portillo MC, Rodriguez-Blazquez C, Martínez-Castrillo JC, Rodriguez-Violante M, Serrano-Dueñas M, Campos-Arillo V, Garretto NS, Arakaki T, Álvarez M, Pedroso-Ibáñez I, Carvajal A, Martinez-Martin P.

Parkinsonism Relat Disord. 2016 Apr;25:52-7. doi: 10.1016/j.parkreldis.2016.02.012. Epub 2016 Feb 15.

PMID:
26905015
8.

Correction: A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need.

Ray Chaudhuri K, Rojo JM, Schapira AH, Brooks DJ, Stocchi F, Odin P, Antonini A, Brown RG, Martinez-Martin P.

PLoS One. 2016 Feb 19;11(2):e0150130. doi: 10.1371/journal.pone.0150130. eCollection 2016.

9.

Effect of heat waves on morbidity and mortality due to Parkinson's disease in Madrid: A time-series analysis.

Linares C, Martinez-Martin P, Rodríguez-Blázquez C, Forjaz MJ, Carmona R, Díaz J.

Environ Int. 2016 Apr-May;89-90:1-6. doi: 10.1016/j.envint.2016.01.017. Epub 2016 Jan 26.

PMID:
26824434
10.

Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis.

Martinez-Martín P, Rodriguez-Blazquez C, Paz S, Forjaz MJ, Frades-Payo B, Cubo E, de Pedro-Cuesta J, Lizán L; ELEP Group.

PLoS One. 2015 Dec 23;10(12):e0145310. doi: 10.1371/journal.pone.0145310. eCollection 2015.

11.

Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease.

Martinez-Martin P, Leentjens AF, de Pedro-Cuesta J, Chaudhuri KR, Schrag AE, Weintraub D.

Mov Disord. 2016 Mar;31(3):270-9. doi: 10.1002/mds.26522. Epub 2015 Dec 22. Review.

PMID:
26695691
12.

Modeling anxiety in Parkinson's disease.

Broen MP, Köhler S, Moonen AJ, Kuijf ML, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Leentjens AF.

Mov Disord. 2016 Mar;31(3):310-6. doi: 10.1002/mds.26461. Epub 2015 Dec 21.

PMID:
26685935
13.

[A pilot study on the living with a chronic process scale in patients with Parkinson's disease].

Ambrosio L, Portillo MC, Rodríguez-Blázquez C, Carvajal A, Martínez-Martín P.

Rev Neurol. 2015 Nov 16;61(10):447-53. Spanish.

14.

Estimating the direct and indirect costs associated with Parkinson's disease.

Rodríguez-Blázquez C, Forjaz MJ, Lizán L, Paz S, Martínez-Martín P.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):889-911. doi: 10.1586/14737167.2015.1103184. Epub 2015 Oct 29.

PMID:
26511768
15.

Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group.

Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19.

PMID:
26494524
16.

The Vallecas Project: A Cohort to Identify Early Markers and Mechanisms of Alzheimer's Disease.

Olazarán J, Valentí M, Frades B, Zea-Sevilla MA, Ávila-Villanueva M, Fernández-Blázquez MÁ, Calero M, Dobato JL, Hernández-Tamames JA, León-Salas B, Agüera-Ortiz L, López-Álvarez J, Larrañaga P, Bielza C, Álvarez-Linera J, Martínez-Martín P.

Front Aging Neurosci. 2015 Sep 30;7:181. doi: 10.3389/fnagi.2015.00181. eCollection 2015.

17.

Correction: Comparative Incidence of Conformational, Neurodegenerative Disorders.

de Pedro-Cuesta J, Rábano A, Martínez-Martín P, Ruiz-Tovar M, Alcalde-Cabero E, Almazán-Isla J, Avellanal F, Calero M.

PLoS One. 2015 Oct 6;10(10):e0140304. doi: 10.1371/journal.pone.0140304. eCollection 2015. No abstract available.

18.

Social robots in advanced dementia.

Valentí Soler M, Agüera-Ortiz L, Olazarán Rodríguez J, Mendoza Rebolledo C, Pérez Muñoz A, Rodríguez Pérez I, Osa Ruiz E, Barrios Sánchez A, Herrero Cano V, Carrasco Chillón L, Felipe Ruiz S, López Alvarez J, León Salas B, Cañas Plaza JM, Martín Rico F, Abella Dago G, Martínez Martín P.

Front Aging Neurosci. 2015 Sep 3;7:133. doi: 10.3389/fnagi.2015.00133. eCollection 2015.

19.

Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease.

Dafsari HS, Reddy P, Herchenbach C, Wawro S, Petry-Schmelzer JN, Visser-Vandewalle V, Rizos A, Silverdale M, Ashkan K, Samuel M, Evans J, Huber CA, Fink GR, Antonini A, Chaudhuri KR, Martinez-Martin P, Timmermann L; IPMDS Non-Motor Symptoms Study Group.

Brain Stimul. 2016 Jan-Feb;9(1):78-85. doi: 10.1016/j.brs.2015.08.005. Epub 2015 Aug 19.

PMID:
26385442
20.

Improvement of dyskinesias with l-dopa infusion in advanced Parkinson's disease.

Timpka J, Fox T, Fox K, Honig H, Odin P, Martinez-Martin P, Antonini A, Ray Chaudhuri K.

Acta Neurol Scand. 2016 Jun;133(6):451-8. doi: 10.1111/ane.12483. Epub 2015 Sep 11.

PMID:
26358227
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk